NCT01788605

Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation

Prospective, Single-arm Phase 2 Trial to Evaluate Efficacy and Safety of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation for Hematologic Malignancies

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 65 (estimated)
• Sponsor: The Catholic University of Korea · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

1. The purpose of this study is to determine the efficacy of ramosetron for the prevention of emesis and the control of nausea and vomiting despite of the prophylactic antiemetic treatment during hematopoietic stem cell transplantation 2. The study hypothesis is that ramosetron is effective for the prevention of emesis and control of emesis and/or vomiting that develop after the prophylactic antiemetic therapy in the setting of hematopoietic stem cell transplantation

Conditions

• Hematologic Malignancies

Interventions

Type	Name	Description
DRUG	ramosetron

Timeline

• Start date: 2014-08-01
• Primary completion: 2014-12-01
• Completion: 2015-02-01
• First posted: 2013-02-11
• Last updated: 2014-12-08

Locations

1 site across 1 country: South Korea